These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
893 related articles for article (PubMed ID: 9762452)
1. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
2. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa. Girod SC; Krueger G; Pape HD Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568 [TBL] [Abstract][Full Text] [Related]
3. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. Yan JJ; Tzeng CC; Jin YT J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. Sousa FA; Paradella TC; Carvalho YR; Rosa LE J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma. de Sousa FA; Paradella TC; Carvalho YR; Rosa LE Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907 [TBL] [Abstract][Full Text] [Related]
7. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231 [TBL] [Abstract][Full Text] [Related]
8. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices. Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595 [TBL] [Abstract][Full Text] [Related]
9. Midkine expression in oral squamous cell carcinoma and leukoplakia. Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225 [TBL] [Abstract][Full Text] [Related]
11. Expression of the tumour suppressor gene p53 in oral cancer. Langdon JD; Partridge M Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822 [TBL] [Abstract][Full Text] [Related]
12. Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858 [TBL] [Abstract][Full Text] [Related]
13. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis. Li XJ; Murai M; Koyama T; Wang DY; Hashimoto K Jpn J Cancer Res; 2000 May; 91(5):492-8. PubMed ID: 10835493 [TBL] [Abstract][Full Text] [Related]
14. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. Agarwal S; Mathur M; Srivastava A; Ralhan R Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158 [TBL] [Abstract][Full Text] [Related]
15. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. Nylander K; Dabelsteen E; Hall PA J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683 [TBL] [Abstract][Full Text] [Related]
16. p53 and MDM2 expression in oral squamous cell carcinoma. Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE Oncology; 1996; 53(4):308-12. PubMed ID: 8692535 [TBL] [Abstract][Full Text] [Related]
17. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium. Ichikawa M; Ishii K; Nakajima T; Mogi K J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738 [TBL] [Abstract][Full Text] [Related]
18. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543 [TBL] [Abstract][Full Text] [Related]
19. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. Ogmundsdóttir HM; Björnsson J; Holbrook WP J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. Shintani S; Yoshihama Y; Emilio AR; Matsumura T Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]